Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

EMEA hospital sector finishes 2020 strongly

Private hospital operators across Europe, the Middle East and South Africa had a good last few months of trading in what was a turbulent 2020, but the start of 2021 looks tougher. We talk to operators across the region.

Amedes for sale as Synlab forecasts future organic growth to settle about 3%

Europe's largest lab group Synlab forecasts that it will see 3+% of annual organic growth over the mid-term, saying that testing will remain a core part of pandemic control. Other lab groups clearly agree with that punt, with news that smaller rival Amedes reportedly is preparing for sale.

Bergman buys German cosmetic group

Netherlands-based ambulatory and ophthalmology clinic group Bergman Clinics, currently exploring a sale that could raise over €1bn, has acquired German aesthetic surgical treatments platform Medical One.

Regional Czech governments look to PPPs to meet care home demands

In a notable shift in policy, regional Czech governments have started entering into PPPs with local operators to build additional nursing home capacity. Substantial contracts to for-profit operators could follow, according to a CEE-based expert.

The evidence needed for health apps is changing

The quick rise of health apps has meant processes for approval and reimbursement have largely replicated ones for bringing new drugs to market. That is now starting to change, with many of the new reimbursement schemes recognising a need for real-world evidence over randomised clinical trials and new standards being created specifically for apps.

Carlyle to exit Ameos in H2

Private equity firm Carlyle will exit German and Swiss acute/psychiatric hospital operator Ameos Group in the second half of this year, a spokesperson for Ameos tells HBI. Reports say that CEO Dr Axel Paeger and London-listed Intermediate Capital Group (ICG) will become controlling shareholders.

Ameos sale/refinancing: Speculation mounts as group denies discussions

Despite emphatic denials from the company itself that it is for sale, multiple sources continue to tell HBI that DACH psychiatry and acute hospital group Ameos is in discussion with potential suitors and that documentation preparing for refinancing and/or sale has been drawn up. HBI speaks to an operator source, a consultant, and the company to find out more.

Find Us